WILL HAVER Founding CEO, Haver AI Boston, MA — willhaver.com — will@haverai.com Last updated: 2026-05-10 SHORT BIO (≈40 words) Will Haver is the founding CEO of Haver AI, building agentic AI in healthcare out of Harvard Innovation Labs. He leads the development of Harrison-1, a healthcare LLM developed in collaboration with NVIDIA, and works with MIT and Harvard Medical School on clinical research. MEDIUM BIO (≈110 words) Will Haver is a founder and agentic AI researcher building Haver AI, a healthcare AI company working out of Harvard Innovation Labs. Haver AI develops infrastructure and clinical tooling for accountable care organizations and the providers working inside them — including Harrison-1, a healthcare LLM developed in collaboration with NVIDIA. Will co-authored research with MIT and Harvard Medical School on predicting potentially preventable hospital admissions, and presented the work at the MIT × Mass General Brigham AI Cures conference. Before Haver AI, he founded Haver LP, a quantitative hedge fund. He advises Marbella AI and teaches AI workshops at Harvard. LONG BIO (≈230 words) Will Haver is the founding CEO of Haver AI, a healthcare AI company incubated at Harvard Innovation Labs. Haver AI builds governance-grade infrastructure and clinical decision tooling for accountable care organizations and the providers working inside them, anchored by Harrison-1 — a healthcare LLM developed in collaboration with NVIDIA. He co-authored a pilot study with MIT and Harvard Medical School on predicting potentially preventable hospital admissions across an ACO's patient pool, and presented the research at the MIT × Mass General Brigham AI Cures conference. With co-founders Vikas Bommineni, Arthur Belkin, and Le Qi, Haver AI was a semifinalist in Harvard's President's Innovation Challenge in the Health & Life Sciences track. Will is a regular speaker and teacher: he co-taught the OpenClaw and Claude Cowork workshops at Harvard and was a Distinguished Guest Speaker at Columbia University's 2026 Global Sustainability Summit. He also serves as an advisor and board member at Marbella AI. Before Haver AI, Will founded Haver LP, a quantitative hedge fund focused on high-frequency trading and convertible debt arbitrage. The crossover between markets infrastructure and clinical AI shows up in how he builds — fast, instrumented, and obsessed with the failure modes nobody else is watching. He lives and works in Boston, MA. CONTACT Email: will@haverai.com LinkedIn: https://linkedin.com/in/will-haver/ Personal: https://willhaver.com Company: https://haver.ai